FIELD: medicine.
SUBSTANCE: method involves administering tetrahydrocannabinol derivatives for inhibiting cell proliferation in mammalians.
EFFECT: enhanced effectiveness of treatment.
17 cl, 4 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DECREASING CELL PROLIFERATION BASED UPON (3R,4R)- ▵8-TETRAHYDROCANNABINOL-11-ONIC ACIDS (HEMP-OBTAINED ACIDS) | 2001 |
|
RU2272620C2 |
| METHODS OF TREATING CANCER DISEASES AND TUMORS USING PDE1 INHIBITORS | 2019 |
|
RU2811918C2 |
| PROLYL HYDROXYLASE INHIBITORS | 2010 |
|
RU2518071C2 |
| COMBINED C-MET AND EGFR ANTAGONISTS THERAPY | 2009 |
|
RU2601892C2 |
| AZAINDOLIZINES AND METHODS FOR PREPARING THEM | 2008 |
|
RU2483069C2 |
| NEW CANNABIDIOL QUINONE DERIVATIVES | 2014 |
|
RU2667504C2 |
| METHODS FOR INCREASING STABILISATION OF HYPOXYA INDUCED FACTOR-1 ALPHA | 2010 |
|
RU2521251C2 |
| ANTI-TUMOUR EFFECTS OF COMBINATIONS OF CANNABIS COMPOUNDS | 2009 |
|
RU2546284C2 |
| NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
| ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS FOR USING IT | 2006 |
|
RU2448703C2 |
